Drug
marstacimab-hncq
Marketed as HYMPAVZI.
Generic name
marstacimab-hncq
Brand names
HYMPAVZI
First FDA approval
2024-10-11
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761369 | HYMPAVZI | 2024-10-11 | PFIZER INC |
Manufacturers
PFIZER INC
Frequently asked questions
When was marstacimab-hncq FDA approved?
Earliest FDA approval on record: 2024-10-11.
What brand names are sold as marstacimab-hncq?
HYMPAVZI.
Sources
Appeal a marstacimab-hncq denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com